Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-E- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
Details for Australian Patent Application No. 2008236444 (hide)
International Classifications
Event Publications
5 November 2009 PCT application entered the National Phase
PCT publication WO2008/122858 Priority application(s): WO2008/122858
7 January 2010 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from McLaughling, Robert William to McLaughlin, Robert William
28 June 2012 Application Accepted
Published as AU-B-2008236444
25 October 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008236474-Compositions and methods for water and gas shut-off in subterranean wells with VES fluids
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser